These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25825444)

  • 1. Coordinated expression of DNAM-1 and LFA-1 in educated NK cells.
    Enqvist M; Ask EH; Forslund E; Carlsten M; Abrahamsen G; Béziat V; Andersson S; Schaffer M; Spurkland A; Bryceson Y; Önfelt B; Malmberg KJ
    J Immunol; 2015 May; 194(9):4518-27. PubMed ID: 25825444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: DNAX accessory molecule 1-deficient CD8+ T cells display immunological synapse defects that impair antitumor immunity.
    Ramsbottom KM; Hawkins ED; Shimoni R; McGrath M; Chan CJ; Russell SM; Smyth MJ; Oliaro J
    J Immunol; 2014 Jan; 192(2):553-7. PubMed ID: 24337740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
    Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
    Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cell recognition and killing of melanoma cells is controlled by multiple activating receptor-ligand interactions.
    Morgado S; Sanchez-Correa B; Casado JG; Duran E; Gayoso I; Labella F; Solana R; Tarazona R
    J Innate Immun; 2011; 3(4):365-73. PubMed ID: 21576932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two-pore domain K2 P channel TASK2 drives human NK-cell proliferation and cytolytic function.
    Schulte-Mecklenbeck A; Bittner S; Ehling P; Döring F; Wischmeyer E; Breuer J; Herrmann AM; Wiendl H; Meuth SG; Gross CC
    Eur J Immunol; 2015 Sep; 45(9):2602-14. PubMed ID: 26140335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.
    Carlsten M; Norell H; Bryceson YT; Poschke I; Schedvins K; Ljunggren HG; Kiessling R; Malmberg KJ
    J Immunol; 2009 Oct; 183(8):4921-30. PubMed ID: 19801517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro.
    Feng S; Madsen SH; Viller NN; Neutzsky-Wulff AV; Geisler C; Karlsson L; Söderström K
    Immunology; 2015 Jul; 145(3):367-79. PubMed ID: 25684021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity.
    Xiong P; Sang HW; Zhu M
    Immunology; 2015 Nov; 146(3):369-78. PubMed ID: 26235210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD226 is associated to but not required for NK cell education.
    Wagner AK; Kadri N; Snäll J; Brodin P; Gilfillan S; Colonna M; Bernhardt G; Höglund P; Kärre K; Chambers BJ
    Nat Commun; 2017 May; 8():15627. PubMed ID: 28561023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In contrast to anti-tumor activity, YT cell and primary NK cell cytotoxicity for Cryptococcus neoformans bypasses LFA-1.
    Jones GJ; Wiseman JC; Marr KJ; Wei S; Djeu JY; Mody CH
    Int Immunol; 2009 Apr; 21(4):423-32. PubMed ID: 19261694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
    J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of self-ligands for activating natural killer cell receptors.
    Lam RA; Chwee JY; Le Bert N; Sauer M; Pogge von Strandmann E; Gasser S
    Ann Med; 2013 Jun; 45(4):384-94. PubMed ID: 23701136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Competence of NK Cells via the KIR/MHC Class I Interaction Correlates with DNAM-1 Expression.
    Shang QN; Yu XX; Xu ZL; Cao XH; Liu XF; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ; Zhao XY
    J Immunol; 2022 Jan; 208(2):492-500. PubMed ID: 34937746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNAM-1 controls NK cell activation via an ITT-like motif.
    Zhang Z; Wu N; Lu Y; Davidson D; Colonna M; Veillette A
    J Exp Med; 2015 Nov; 212(12):2165-82. PubMed ID: 26552706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular ligands of activating NK receptors.
    Bottino C; Castriconi R; Moretta L; Moretta A
    Trends Immunol; 2005 Apr; 26(4):221-6. PubMed ID: 15797513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.